Reference : Synthesis and pharmacological evaluation of a new targeted drug carrier system: β-Cyc...
Scientific journals : Article
Human health sciences : Pharmacy, pharmacology & toxicology
http://hdl.handle.net/2268/41495
Synthesis and pharmacological evaluation of a new targeted drug carrier system: β-Cyclodextrin coupled to oxytocin
English
Bertolla, C [Université de Liège - ULg > Département de pharmacie > Pharmacie galénique >]
Rolin, S [> > > >]
Evrard, Brigitte mailto [> > > >]
Pochet, L [> > > >]
Masereel, B [> > > >]
2008
Bioorganic & Medicinal Chemistry Letters
18
1855-1858
Yes
International
[en] β-Cyclodextrin (β-CD) was monofunctionalized into its carboxylic derivative and then conjugated to the N-side of oxytocin (OT), a nonapeptide involved in human behavior and myometrium contraction. On isolated rat myometrium, this conjugate (β-CD-OT) partly preserves the contracting activity of OT (EC50 = 0.40 μM vs 1.7 nM). Moreover, the contraction induced frequency is also lowered by β-CD-OT. This novel hydrophilic targeted carrier could form a host–guest complex with prostaglandins and their derivatives used as labor inducers or with anticancer drugs used in cervix and endometrial cancer. This strategy can improve the solubility, the stability, and/or the biological activity of these drugs as well as reducing their side-effects.
http://hdl.handle.net/2268/41495

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
bertolla_2008.pdfNo commentaryPublisher postprint134.29 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.